These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27378363)

  • 1. Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration.
    Nsaibia MJ; Mahmut A; Mahjoub H; Dahou A; Bouchareb R; Boulanger MC; Després JP; Bossé Y; Arsenault BJ; Larose E; Pibarot P; Mathieu P
    Heart; 2016 Dec; 102(23):1915-1921. PubMed ID: 27378363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.
    Salaun E; Mahjoub H; Dahou A; Mathieu P; Larose É; Després JP; Rodés-Cabau J; Arsenault BJ; Puri R; Clavel MA; Pibarot P
    J Am Coll Cardiol; 2018 Jul; 72(3):241-251. PubMed ID: 30012316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration.
    Mahjoub H; Mathieu P; Sénéchal M; Larose E; Dumesnil J; Després JP; Pibarot P
    J Am Coll Cardiol; 2013 Feb; 61(7):752-61. PubMed ID: 23410546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses.
    Shetty R; Girerd N; Côté N; Arsenault B; Després JP; Pibarot P; Mathieu P
    Cardiology; 2012; 121(1):20-6. PubMed ID: 22378142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Bioprosthetic Aortic Valve Degeneration.
    Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lp-PLA2 is associated with structural valve degeneration of bioprostheses.
    Mahmut A; Mahjoub H; Boulanger MC; Fournier D; Després JP; Pibarot P; Mathieu P
    Eur J Clin Invest; 2014 Feb; 44(2):136-45. PubMed ID: 24328921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.
    Salaun E; Mahjoub H; Girerd N; Dagenais F; Voisine P; Mohammadi S; Yanagawa B; Kalavrouziotis D; Juni P; Verma S; Puri R; Coté N; Rodés-Cabau J; Mathieu P; Clavel MA; Pibarot P
    Circulation; 2018 Sep; 138(10):971-985. PubMed ID: 30354532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement.
    Hamamoto M; Kobayashi T; Ozawa M; Yoshimura K
    Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):157-160. PubMed ID: 27980283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
    Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
    J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial?
    Kulik A; Masters RG; Bédard P; Hendry PJ; Lam BK; Rubens FD; Mesana TG; Ruel M
    Eur J Cardiothorac Surg; 2010 Jan; 37(1):139-44. PubMed ID: 19674916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mosaic porcine bioprosthesis: role of age on clinical performance in aortic position.
    Riess FC; Bader R; Cramer E; Hansen L; Schiffelers S; Wallrath J; Wahl G
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1440-8.e1. PubMed ID: 20850804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
    Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
    J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
    Gotzmann M; Mügge A; Bojara W
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1000-6. PubMed ID: 20824744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD14 is associated with the structural failure of bioprostheses.
    Nsaibia MJ; Boulanger MC; Bouchareb R; Mkannez G; Dahou A; Salaun E; Bossé Y; Clavel MA; Arsenault BJ; Pibarot P; Mathieu P
    Clin Chim Acta; 2018 Oct; 485():173-177. PubMed ID: 29966619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary perfusion: impact of flow dynamics and geometric design of 2 different aortic prostheses of similar size.
    Mannacio V; Di Tommaso L; De Amicis V; Stassano P; Vosa C
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1030-5. PubMed ID: 21752400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of aortic bioprosthetic valve structural degeneration.
    Salaun E; Côté N; Clavel MA; Pibarot P
    Curr Opin Cardiol; 2019 Mar; 34(2):132-139. PubMed ID: 30562183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses.
    Seiffert M; Conradi L; Baldus S; Knap M; Schirmer J; Franzen O; Koschyk D; Meinertz T; Reichenspurner H; Treede H
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):617-24. PubMed ID: 22169448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitroflow LXA structural deterioration following aortic valve replacement: a single-center experience.
    Zannis K; Diplaris K; Monin JL; Khelil N; Debauchez M; Dervanian P; Lansac E; Czirom D; Noghin M; Mankoubi L; Amabile N
    J Cardiovasc Surg (Torino); 2018 Oct; 59(5):746-752. PubMed ID: 29786406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.